207 related articles for article (PubMed ID: 27327081)
21. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
Lellé RJ; Henkel E; Leinemann D; Goeschen K
Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
[TBL] [Abstract][Full Text] [Related]
22. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
23. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites.
Trapé J; Gurt G; Franquesa J; Montesinos J; Arnau A; Sala M; Sant F; Casado E; Ordeig JM; Bergos C; Vida F; Sort P; Isava Á; González M; Molina R
Anticancer Res; 2015 Oct; 35(10):5655-60. PubMed ID: 26408739
[TBL] [Abstract][Full Text] [Related]
25. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
Ng WW; Tong KJ; Tam TN; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
[TBL] [Abstract][Full Text] [Related]
26. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125--results in immune and clinical responses in breast cancer patients.
Jiang XP; Yang DC; Elliott RL; Head JF
Cancer Biother Radiopharm; 2000 Oct; 15(5):495-505. PubMed ID: 11155821
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
[TBL] [Abstract][Full Text] [Related]
29. Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy.
Zhang Y; Zhao J; Wang Y; Cai W; Zhang X; Li K; Liu W; Zhao Y; Kang H
Dis Markers; 2022; 2022():7739777. PubMed ID: 35634442
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
[TBL] [Abstract][Full Text] [Related]
31. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
32. [Cancer clearance for "unprovoked" venous thromboembolism cases].
Ye W; Chen Y; Li M; Jiang C; Li D; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(15):1143-6. PubMed ID: 24924711
[TBL] [Abstract][Full Text] [Related]
33. Heat shock protein 90α in nipple discharge as a potential tumor marker for breast cancer.
Wang YY; Liu C; Chen X; Ji J; Zhu SL; Sun Q; Zhang K; Zhu J; Zhao S; Wang YW; Ma R; Wang JL
Chin J Physiol; 2021; 64(5):251-256. PubMed ID: 34708717
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of serum biomarkers CA153, CEA, and white blood cells in predicting sentinel lymph node metastasis of breast cancer.
Fan Y; Chen X; Li H
Int J Clin Exp Pathol; 2020; 13(11):2889-2894. PubMed ID: 33284901
[TBL] [Abstract][Full Text] [Related]
35. [Clinical usefulness of carcinoembryonic antigen measurement in nipple discharge as an adjunctive tool for diagnosis of breast cancer].
Nishiguchi T; Hishimoto T; Funahashi S; Takatsuka Y; Kawahara T
Rinsho Byori; 1992 Jan; 40(1):67-72. PubMed ID: 1545528
[TBL] [Abstract][Full Text] [Related]
36. ErbB-2 protein levels in nipple discharge: role in diagnosis of early breast cancer.
Inaji H; Koyama H; Motomura K; Noguchi S; Mori Y; Kimura Y; Sugano K; Ohkura H
Tumour Biol; 1993; 14(5):271-8. PubMed ID: 7901888
[TBL] [Abstract][Full Text] [Related]
37. The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer.
Zhang J; Wei Q; Dong D; Ren L
Clin Chim Acta; 2021 Dec; 523():19-25. PubMed ID: 34454906
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of total prostate specifc antigen (TPSA) in women with breast cancer in the molecular subtyping era.
Zhang L; Yu X; Zhou L; Yang Y; Liu S
J BUON; 2018; 23(5):1316-1324. PubMed ID: 30570853
[TBL] [Abstract][Full Text] [Related]
39. [Early detection of non-palpable (T0) breast cancer: the diagnostic procedure for pathological discharge from the nipple].
Yayoi E; Furukawa J; Sekimoto M; Tateishi H; Kinuta M; Maruyama H; Okamura J
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():133-9. PubMed ID: 8037475
[TBL] [Abstract][Full Text] [Related]
40. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
